Candidate gene discovery procedure after follow-up confirmatory analyses of candidate regions of interests for Alzheimer's disease in the NIMH sibling dataset

Disease Markers

Volumn 24, Issue 6, 2008, Pages 293-309

  Baye, Tesfaye M ^a   Perry, Rodney T ^a   Wiener, Howard W ^a   Chen, Zuomin ^a   Harrell, Lindy E ^b   Go, Rodney C P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Alzforum; Alzgene database; Alzheimer; Bioinformatics; Candidate gene; Gene ontology; Genomic scan; GO; Linkage; QTL; SNP; STR

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER;

ACE GENE; ADULT; AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; BDNF GENE; CH25H GENE; CHRNB2 GENE; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 3P; CHROMOSOME 6Q; CHROMOSOME 9Q; CONTROLLED STUDY; CST3 GENE; CTSD GENE; DAPK1 GENE; DISEASE MARKER; FAMILY; FOLLOW UP; GALP GENE; GENE; GENE IDENTIFICATION; GENE MAPPING; GENETIC DATABASE; GENETIC LINKAGE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HMGCS2 GENE; HUMAN; IL1B GENE; LMNA GENE; MAJOR CLINICAL STUDY; MAPT GENE; MYH13; NUCLEOTIDE SEQUENCE; PCK1 GENE; PGBD1 GENE; PON1 GENE; PRIORITY JOURNAL; PRNP GENE; PSEN1 GENE; SHORT TANDEM REPEAT; SIBLING; SIGNAL TRANSDUCTION; SOAT1 GENE; SORCS1 GENE; SORL1 GENE; TF GENE; TNK1 GENE;

EID: 49149084793     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/736409     Document Type: Article

References (46)

1. D. Blacker, L. Bertram, A.J. Saunders, T.J. Moscarillo, M.S. Albert, H. Wiener, R.T. Perry, J.S. Collins, L.E. Harrell, R.C. Go et al., Results of a high-resolution genome screen of 437 Alzheimer's disease families, Hum Mol Genet 12(1) (2003), 23-32.
2. R.T. Perry, H. Wiener, L.E. Harrell, D. Blacker, R.E. Tanzi, L. Bertram, S.S. Bassett and R.C. Go, Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort, Am J Med Genet B Neuropsychiatr Genet 144B (2007), 220-227.
3. D.T. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev 81 (2001), 741-766.
4. R. Guttman, R.D. Altman and N.H. Nielsen, Alzheimer disease. Report of the council on scientific affairs, Arch Fam Med 8(4) (1999), 347-353.
5. A. Lobo, L.J. Launer, L. Fratiglioni, K. Andersen, A. Di Carlo, M.M. Breteler, J.R. Copeland, J.F. Dartigues, C. Jagger, J. Martinez-Lage, H. Soininen and A. Hofman, Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology 54 (2000), S4-S9.
6. R.F. Itzhaki and M.A. Wozniak, Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders, Prog Lipid Res 1 (2006), 73-90.
7. R.E. Tanzi, A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders, J Clin Invest 104(9) (1999), 1175-1179.
8. R. Sherrington, E.I. Rogaev, Y. Liang et al., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature 375 (1995), 754-760.
9. E. Levy-Lahad, W. Wasco, P. Poorkaj et al., Candidate gene for the chromosome 1 familial Alzheimer's disease locus, Science 269 (1995), 973-977.
10. A. M. Goate, M.-C. Chartier-Harlin, M.C., Mullan et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
11. N. Ertekin-Taner, Genetics of Alzheimer's disease: a centennial review, Neurol Clin 25(3) (2007), 611-667.
12. A.D. Roses, A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease, Neurogenetics 1(1) (1997), 3-11.
13. A.J. Slooter, M. Cruts, S. Kalmijn, A. Hofman, M.M. Breteler, C. Van Broeckhoven and C.M. van Duijn, Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study, Arch Neurol 55(7) (1998), 964-968.
14. M.L. Hamshere, P.A. Holmans, D. Avramopoulos, S.S. Bassett, D. Blacker, L. Bertram, H. Wiener, N. Rochberg, R.E. Tanzi, A. Myers, V.F. Wavrant-De, R. Go, D. Fallin, S. Lovestone, J. Hardy, A. Goate, M. O'donovan, J.Williams and M.J. Owen, Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's Disease, Hum Mol Genet (Aug 27, 2007), Epub ahead of print.
15. L. Bertram and R.E. Tanzi, The current status of Alzheimer's disease genetics: what do we tell the patients? Pharmacol Res 50(4) (2004), 385-396.
16. A.S. Khachaturian, C.D. Corcoran; L.S Mayer, P.P Zandi and J.C.S Breitner, Apolipoprotein E 4 Count Affects Age at Onset of Alzheimer Disease, but Not Life time Susceptibility: The Cache County Study, Arch Gen Psychiatry 61 (2004), 518-524.
17. M.I. Kamboh, Molecular genetics of late-onset Alzheimer's disease, Ann Hum Genet 68 (2004), 381-404.
18. P. Kehoe, F. Wavrant-De Vrieze, R. Crook, W.S. Wu, P. Holmans, I. Fenton, G. Spurlock, N. Norton, H. Williams, N. Williams et al., A full genome scan for late onset Alzheimer's disease, Hum Mol Genet 8(2) (1999), 237-245.
19. M.A. Pericak-Vance, J. Grubber, L.R. Bailey, D. Hedges, S. West, L. Santoro, B. Kemmerer, J.L. Hall, A.M. Saunders, A.D. Roses et al., Identification of novel genes in late-onset Alzheimer's disease, Exp Gerontol 35(9-10) (2000), 1343-1352.
20. A. Myers, F. Wavrant De-Vrieze, P. Holmans, M. Hamshere, R. Crook, D. Compton, H. Marshall, D. Meyer, S. Shears, J. Booth et al., Full genome screen for Alzheimer disease: stage II analysis, Am J Med Genet 114(2) (2002), 235-244.
21. A. Sillen, C. Forsell, L. Lilius, K. Axelman, B.F. Bjork, P. Onkamo, J. Kere, B. Winblad and C. Graff, Genome scan on Swedish Alzheimer's disease families, Mol Psychiatry 11(2) (2006), 182-186.
22. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker and R.E. Tanzi, Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database, Nat Genet 39(1) (2007), 17-23.
23. J.H. Lee, Mayeux, R. Mayo, D. Mo, J. Santana, V. Williamson, J. Flaquer, A. Ciappa, A. Rondon, H. Estevez et al., Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics, Mol Psychiatry 9 (2004), 1042-1051.
24. G. McKhann, D. Drachman, M. Folstein et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease, Neurol 34 (1984), 939-944.
25. M.C. Tierney, R.H. Fisher, A.J. Lewis, M.L. Zorzitto, W.G. Snow, D.W. Reid and P. Nieuwstraten, The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases, Neurology 38(3) (1988), 359-364.
26. J.S. Collins, R.T. Perry, B. Watson, L.E. Harrell, R.T. Acton, D. Blacker, M.S. Albert, R.E. Tanzi, S.S. Bassett, M.G. McInnis, R.D. Campbell and R.C. Go, Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative, Am J Med Genet 96 (2000), 823-830.
27. A. Kong and N.J. Cox, Allele-sharing models: LOD scores and accurate linkage tests, Am J Hum Genet 61(5) (1997), 1179-1188.
28. L. Kruglyak, M.J. Daly, M.P. Reeve-Daly and E.L. Lander, Parametric and nonparametric linkage analysis: a unified multipoint approach, Am J Hum Genet 58 (1996), 1347-1363.
29. S.A.G.E., Statistical analysis for genetic epidemiology. Version 5.0. (2002) Cork: Statistical Solutions Ltd.
30. M.P. Mattson, Pathways towards and away from Alzheimer's disease, Nature 430(7000) (2004), 631-639.
31. J.D. Terwilliger and J. Ott, Handbook of Human Genetic Linkage, Baltimore: Johns Hopkins University Press, 1994, 320.
32. D.M. Evans and L.R. Cardon, Guidelines for genotyping in genome-wide linkage studies: Single-nucleotide-polymorphism maps versus microsatellite maps, Am J Hum Genet 75(4) (2004), 687-692.
33. E. Lander and L. Kruglyak, Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results, Nat Genet 11(3) (1995), 241-247.
34. S. Hoffjan and C. Ober, Present status on the genetic studies of asthma, Current Opinion in Immunology 14 (2002), 709-717.
35. B.A. Raby, E.K. Silverman, R. Lazarus, C. Lange, D.J. Kwiatkowski and S.T. Weiss, Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes, Hum Mol Genet 12 (2003), 1973-1979.
36. E. Noguchi, Y. Yokouchi, J. Zhang, K. Shibuya, A. Shibuya and M. Bannai, Positional identification of an asthma susceptibility gene on human chromosome 5q33, Am J Respir Crit Care Med 172 (2005), 183-188.
37. D. Thomas, Are we ready for genome-wide association studies? Cancer Epidemiol Biomarkers Prev 15 (2006), 595-598.
38. M. Li, M. Boehnke and G. R. Abecasis, Joint modeling of linkage and association identifying SNPs responsible for a linkage signal, Am J Hum Genet 76(6) (2005), 934-949.
39. M.L. Wayne and L.M. McIntyre, Combining mapping and arraying: An approach to candidate gene identification, Proc Natl Acad Sci USA 99(23) (2002), 14903-14906.
40. N. Tiffin, E. Adie, F. Turner, H.G. Brunner et al., Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes, Nucl Acids Res 34 (2006), 3067-3081.
41. T. Toyoda and Y. Takigawa, Selection of Candidate Genes for Polygenic Diseases by Utilizing Protein-Protein Interaction Networks, Genome Informatics 11 (2000), 286-288.
42. F.S. Turner, D.R. Clutterbuck and C.A. Semple, POCUS: mining genomic sequence annotation to predict disease genes, Genome Biology (2003), 4:R75.
43. M. Blurton-Jones and F.M. Laferla, Pathways by which Abeta facilitates tau pathology, Curr Alzheimer Res 3(5) (2006), 437-448.
44. M. Goedert and M.G. Spillantini, A century of Alzheimer's disease, Science 314(5800) (2006), 777-781.
45. C. Ferrer-Costa, M. Orozco and X. de la Cruz, Use of bioinformatics tools for the annotation of disease-associated mutations in animal models, Proteins 61 (2005), 878-887.
46. K.M. Weiss, In search of human variation, Genome Res 8 (1988), 691-697.